Abstract | OBJECTIVE: To performe the immuneserological and RHD Genotype analyses for DVI type 3 genotype pregnemt women with anti-D. METHODS: RhD blood type of this pregnant women was identified by common serological methods, then the blood group specific antibodies was screened and identified; the polymerase chain reaction-sequence specific primer(PCR-SSP) was used to identify the pregnant women's RHD genotype; RhD blood group for the pregnant women, her spouse and daughter was genogrouped and genetically analyzed by multiplex ligation-dependent probe amplification(MLPA). The heredity of this family was analyzed finally. RESULTS: The titer of IgG anti-D in the pregnant woman serum was 1:8; the PCR-SSP showed that the 3rd to 6th exons of RHD gene were missing in the pregnant woman. the genotype of pregnant woman was identified as DVI type 3; the MLPA analysis showed that this pregnant women owned only one RHD allele with 3rd to 6th exons missed, and her genotype was identified as CDVIe/cde; her spouse was identified as CDe/CDe homozygous genotype, and her daughter as CDe/CDVIe. CONCLUSION: Accurate identification of RhD blood type is of great significance for a safe and effective clinical blood transfusion strategy, and for taking appropriate measures to prevent hemolytic disease of newborn (HDN) at women childbearing age.
|
Authors | Qian-Ni Liang, Zhi-Jian Liao, Run-Qing Zhang, Yan-Li Ji, Guang-Ping Luo, Mei-Na Li |
Journal | Zhongguo shi yan xue ye xue za zhi
(Zhongguo Shi Yan Xue Ye Xue Za Zhi)
Vol. 25
Issue 6
Pg. 1810-1814
(Dec 2017)
ISSN: 1009-2137 [Print] China |
PMID | 29262921
(Publication Type: Journal Article)
|
Chemical References |
- RHO(D) antibody
- Rh-Hr Blood-Group System
- Rho(D) Immune Globulin
|
Topics |
- Erythroblastosis, Fetal
(prevention & control)
- Female
- Genotype
- Humans
- Pregnancy
- Rh-Hr Blood-Group System
- Rho(D) Immune Globulin
(genetics, immunology)
|